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Abstract
South Asia has >50% of the global burden of low birth weight (LBW). The objective was to
determine the extent to which maternal nutrition interventions commenced before conception or in the 1st trimester improved fetal growth in this region. This was a secondary analysis
of combined newborn anthropometric data for the South Asian sites (India and Pakistan) in
the Women First Preconception Maternal Nutrition Trial. Participants were 972 newborn of
mothers who were poor, rural, unselected on basis of nutritional status, and had been randomized to receive a daily lipid-based micronutrient supplement commencing �3 months
prior to conception (Arm 1), in the 1st trimester (Arm 2), or not at all (Arm 3). An additional
protein-energy supplement was provided if BMI <20 kg/m2 or gestational weight gain was
less than guidelines. Gestational age was established in the 1st trimester and newborn
anthropometry obtained <48-hours post-delivery. Mean differences at birth between Arm 1
vs. 3 were length +5.3mm and weight +89g. Effect sizes (ES) and relative risks (RR) with
95% CI for Arm 1 vs. 3 were: length-for-age Z-score (LAZ) +0.29 (0.11–0.46, p = 0.0011);
weight-for-age Z-score (WAZ) +0.22 (0.07–0.37, p = 0.0043); weight-to-length-ratio-for-age
Z-score (WLRAZ) +0.27 (0.06–0.48, p = 0.0133); LAZ<-2, 0.56 (0.38–0.82, p = 0.0032);
WAZ <-2, 0.68 (0.53–0.88, p = 0.0028); WLRAZ <-2, 0.76 (0.64–0.89, p = 0.0011); smallfor-gestational-age (SGA), 0.74 (0.66–0.83, p<0.0001); low birth weight 0.81 (0.66–1.00, p
= 0.0461). For Arm 2 vs. 3, LAZ, 0.21 (0.04–0.38); WAZ <-2, 0.70 (0.53–0.92); and SGA,
0.88 (0.79–0.97) were only marginally different. ES or RR did not differ for preterm birth for
either Arm 1 vs. 3 or 2 vs. 3. In conclusion, point estimates for both continuous and binary
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anthropometric outcomes were consistently more favorable when maternal nutrition supplements were commenced �3 months prior to conception indicating benefits to fetal growth of
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Introduction
South Asian (S. Asian) countries, including India, Pakistan, Nepal, and Bangladesh, have wide
intra- and inter-cultural diversity but much in common to encourage a regional perspective
on women’s and children’s nutrition [1]. Despite recent declines in frequency of stunting, 38%
of children under 5 years of age in S. Asia are still stunted, with rates exceeding one-third each
in Pakistan, India, Bangladesh, and Nepal [2]. This region, because of the size of the population
and high rates of stunting, accounts for 40% of the global burden of stunting [2–7]. Though
wasting rates for children under the age of 5 years are lower, they remain unacceptably high,
especially in India, as do rates of underweight in women of childbearing age. Only in Sri Lanka
and Maldives is undernutrition now over-shadowed by excessive rates of obesity and diabetes
[2]. The causes of early childhood stunting in S. Asia, as elsewhere, are multifactorial. However, low birth weight, especially low birth size for gestational age is a major factor [3, 8–10]. S.
Asia accounts for over 50% of the global occurrence of low birth weight (LBW), with both
Pakistan and India being major contributors to this high figure [11]. Furthermore, it has been
postulated quite convincingly that recent figures are underestimates [9]. Even relatively mild
fetal growth retardation is a strong predictor of stunting by two years of postnatal age. This
applies whether the incidence of fetal growth failure is evaluated with birth weight or/and
length measurements [12].
The importance of fetal growth directs attention to the in utero and, therefore, the maternal
environment. Poverty is a common and overriding environmental cause of population fetal
and postnatal growth retardation, and the apparent ‘enigma’ of the very high level of stunting
and wasting in S. Asia has also been attributed specifically to the low social status of women in
poor rural communities [13]. However, other factors contribute, among which malnutrition
has a prominent primary and secondary role requiring specific preventive measures. In one
study, birth size was strongly positively correlated with the intake of micronutrient-rich foods
and with milk and fat intake [14]. Recent reviews of childhood stunting in S. Asia have
included recognition of the importance of maternal nutrition and have given attention to the
nutrition of non-pregnant women [4, 10, 15–20]. Priority attention to eliminating maternal
undernutrition and fetal growth retardation are recognized to be central to health and sustainable development in S. Asia and elsewhere [21–24]. Public health measures focused on attention to nutrition at a community level are contributing to recent progress in India, Nepal,
Bangladesh, and elsewhere [25–29]. However, current statistics reinforce the need to both
ramp-up the application of existing evidence-based strategies and to test new strategies to
improve women’s and, therefore, fetal nutrition [13].
Here we report the newborn anthropometric data for the combined S. Asian sites participating in the Women First Preconception Maternal Nutrition Trial [30].

Objectives
The primary objective of this study was to determine the quantitative improvements in the deficits in birth anthropometry resulting from commencing maternal nutrition supplements at
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least three months prior to conception or in the first trimester of pregnancy in the combined
S. Asian sites participating in the Women First Preconception Maternal Nutrition Trial.

Methods
Ethics
The project was approved by the Colorado Multiple Institutional Review Board, University of
Colorado; JNMC Institutional Ethics Committee on Human Subjects Research and the Indian
Council of Medical Research (India); and The Aga Khan University Ethical Review Committee
(Pakistan); and the Data Coordinating Center. All of these are registered with US Office of
Human Research Protection and with Federal-wide Assurance in place. Written informed
consent was obtained from all participants. The study protocol is available online: https://
www.ncbi.nlm.nih.gov/pmc/articles/PMC4000057/. The Clinical Trial Registry number and
website is ClinicalTrials.gov #NCT01883193; https://clinicaltrials.gov/ct2/show/
NCT01883193?term=01883193&rank=1.

Study design and outcomes
This study was a secondary analysis of neonatal anthropometric outcomes in the Women First
trial [30]. The parent study was an individually randomized, non-masked, multi-site randomized controlled efficacy trial conducted in four sites. The study sites are part of the of the
Eunice Kennedy Shriver NICHD Global Network for Women’s and Children’s Health Research
(GN) and are composed of a total of 24 geographic clusters from the GN Maternal Newborn
Health Registry Each cluster has approximately 300 deliveries per year [31]. The trial included
three arms: Arm 1 started the nutrition supplement for pregnant women at least three months
prior to conception; Arm 2 commenced the same supplement near the end of the first trimester; and Arm 3 which did not receive any trial supplement. This South Asian sub-study was
not included in the original Women First Preconception trial protocol or data analysis plan
but was conceived as a separate sub-study prior to data analyses for those maternal / newborn
dyads who had gestational age determined by ultrasound in the first trimester.
The continuous outcomes reported here by study arm include newborn length, weight,
head circumference (HC), length-for-age Z-score (LAZ), weight-for-age Z-score (WAZ), HCfor-age Z-score (HCAZ), and weight to length ratio-for-age Z-scores (WLRAZ). Categorical
outcomes include small for gestational age (SGA, weight <10th percentile for gestational age),
low birth weight (LBW, <2500 g), preterm birth (PTB, gestational age <37 weeks), LAZ <-2,
WAZ <-2, WLZ <-2 and WLRAZ <-2. Also included are RR for Z-scores <-1 because of
their predictive value for subsequent infant growth [12].

Subjects and randomization
The participants included in this study were newborns whose mothers met all criteria for
inclusion and retention in the parent study and who had ultrasound measurements of crownrump length (CRL) in the first trimester. They were located in resource-poor rural communities in two S. Asian countries (India and Pakistan) and enrolled into the study between January
and December 2014; data collection was completed in March 2017. The mothers of newborns
in Arms 1 and 2 did not receive non-trial nutrition supplements during the trial intervention
period. A high percentage of Arm 3 mothers in the India site received iron-folate supplements
commencing by 12 weeks gestation, but the consumption of prenatal iron-folate was negligible
in the Pakistan site. Women who had twin pregnancies were not excluded.
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The Data Coordinating Center (DCC) created the randomization scheme and centrally
generated the allocation sequence for each site. The scheme included a permuted block design
stratified by GN clusters for assigning individual participants to a trial arm. The allocation
ratio was 1:1:1 within blocks which randomly varied between sizes of 3, 6, or 9 for each site.
Once an eligible participant was identified, the randomization assignment was generated by
the site data manager from the centralized computerized data management system maintained
by the DCC.

Nutrition intervention
The principal intervention was a lipid-based micronutrient supplement (Nutriset, Melauney,
France) which also provided a favorable balance of polyunsaturated fatty acids and small quantities of protein and energy [32]. This product had minor modifications to a product previously designed for pregnant/lactating women [33]. Participants were instructed to take one
sachet daily until delivery.
An additional protein-energy supplement was provided to women whose BMI was <20 kg/
m2 from the time of randomization for Arm 1 participants and from the beginning of the 2nd
trimester for Arm 2 participants. This protein-energy supplement was also provided to any
Arm 1 or Arm 2 participant who failed to meet guidelines for gestational weight gain in the
2nd and 3rd trimesters [34]. Once the second supplement was commenced for either reason, it
was provided until delivery. More than 90% of the women who had live births with newborn
outcome measures received this additional protein energy supplement during the second and
third trimesters.

Anthropometry and measurement of fetal crown-rump length (CRL)
Neonatal recumbent lengths, weights, and head circumferences were obtained within 48 hours
of delivery by trained and periodically certified assessment teams. Measurements were
obtained in triplicate, entered into the database, and the median value used for analysis. Equipment used were neonatal stadiometers (Ellard Instrumentation Ltd, Monroe WA), seca 334
electronic scales, and seca 201 measuring tapes (seca North America, Chino CA). CRL measurements were obtained in the first trimester by ultrasonography.

Home visits and compliance
Participants in all three arms were visited by the home visitor research assistants every two
weeks to record an interim health history and to administer a urine pregnancy test. The pregnancy testing was combined with calendar records of menses to ascertain last menstrual period
and to guide the timing of ultrasounds to be obtained between 10–12 weeks estimated gestation. For Arms 1 and 2, these visits were also used to replenish the supply of trial supplements.
Compliance with supplement(s) use was documented by inspection of calendars the women
completed daily and by collection of empty, partially eaten, and unused intervention sachets.
Compliance was calculated for Supplement 1 as the total number of sachets fully eaten divided
by the number of days between starting Supplement 1 and delivery. Supplement 2 compliance
was calculated similarly; however, the numerator is the total number of Supplement 2 sachets
fully or partially eaten.

Adverse events and safety monitoring
Adverse events were monitored continuously as per protocol [32] and reported to the overall
study principal investigators and the DCC within 48 hours for all deaths and within seven days
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for other adverse events, including adverse pregnancy outcomes, adverse neonatal events, hospitalizations, and allergic reactions. The Data Monitoring Committee reviewed the study progress for safety, trial progress, data completion, supplement compliance, and protocol violations
twice yearly.

Statistical methods
The Intergrowth-21st standards were applied to describe the results of newborn anthropometry [35, 36] in terms of Z-scores and centiles (not shown except for weight-for-age centile
<10th percentile). Study outcomes were assessed with a modified intention-to-treat approach.
The overall treatment effect and pairwise comparisons (Arm 1 vs. Arm 2, Arm 1 vs. 3, as well
as Arm 2 vs. 3) for the continuous anthropometry outcomes were obtained from linear models
for the continuous outcomes (newborn length, weight, HC, LAZ, WAZ, HCAZ, and
WLRAZ). Model-generated measures of ES with 95% confidence intervals (CI) and P values
were adjusted for site and GN cluster nested within site. For binary anthropometry outcomes
(SGA, LBW, PTB, LAZ <-1, LAZ <-2, WAZ <-1, WAZ <-2, WLZ <-1, WLZ <-2, WLRAZ
<-1 and WLRAZ <-2), generalized linear models with generalized estimating equations were
utilized to calculate relative risks with 95% CI and P values after adjusting for site while controlling for GN cluster correlations. P values are presented for descriptive purposes.

Results
Maternal characteristics
Women First participants in the combined S. Asian sites who were screened, enrolled and randomized, had eligible pregnancies, first trimester ultrasound determination of gestational age,
delivered live births, and whose newborn had measurements within 48 hours are given in
Fig 1. Nine hundred and sixty one pregnancies (972 newborns) for the combined S. Asian sites
qualified for inclusion in this analysis. The number of pregnancies ranged from 295–337 per
arm (Table 1). Baseline maternal characteristics for S. Asian mothers with a primary outcome
differed between arms only for maternal education, with a higher percentage of women in
Arms 1 and 3 having no formal education (p = 0.04, Table 1). Mean ± SD duration of exposure
to Supplement for Arm 1 was 72.6 ± 16.8 weeks with overall compliance of 89.6 ± 9.9%. For
Arm 2, duration of exposure to Supplement 1 was 26.3 ± 2.2 weeks with estimated compliance
of 87.7 ± 15.7%. Supplement 2 was started in 67% of Arm 1 women prior to conception and in
an additional 29% during gestation. In Arm 2, 92% of the women received Supplement 2 starting after 12 weeks gestation. The duration of Supplement 2 was 56.2 ± 25.5 weeks for Arm 1
and 23.7 ± 5.1 weeks for Arm 2.

Newborn outcomes
The number of newborn with anthropometric outcomes ranged from 299–340 per arm
(Table 2). Fortuitously the twin pregnancies were equally distributed between the three arms
accounting for 2.5% of total newborn included in this analysis.
Anthropometric measures for controls (Arm 3) were determined by sex. Mean ± SD
lengths were 46.83 ± 2.48 and 47.53 ± 2.67 cm for females and males, respectively. Corresponding figures for weight were 2605 ± 421 and 2731 ± 433 g and for head circumference
were 32.44 ± 1.62 and 33.12 ±1.51 cm. However, the effects of the maternal supplements on
newborn anthropometry did not vary by sex (p = 0.2133). Accordingly, sexes have been combined for all analyses.
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Fig 1. Consort Diagram for Women First Preconception Maternal Nutrition Trial in South Asian region. 1Excludes women who
became pregnant <3 months into the study. The women who had eligible pregnancies may have had delivery data obtained or they
may have exited the study prior to delivery. 2Gestational age (GA) at birth is defined as the age at the time of the ultrasound based on
the ultrasound plus time until birth if the ultrasound was done between 6 weeks + 0 days to 13 weeks + 6 days and the GA at birth is
between 24 weeks + 0 days and 42 weeks + 6 days. 3Primary outcome was obtained for live newborns with three length
measurements taken within 48 hours of delivery. 4Length-for-age, weight-for-age, head circumference-for-age, and weight-lengthratio-for age Z-scores and percentiles based on measurements within 48 hours of age are calculated using the INTERGROWTH-21st
International Standards for Newborn Size [37] and International Standards for Newborn Size for Very Preterm Infants [38] which
provide Z-scores by sex and GA at birth for infants born between 33 weeks + 0 days to 42 weeks + 6 days GA at birth and between 24
weeks + 0 days to 32 weeks + 6 days GA at birth, respectively.
https://doi.org/10.1371/journal.pone.0218960.g001

For the newborns of women who did not receive trial nutrition supplements (Arm 3),
mean LAZ and WAZ were low with WAZ more impaired than LAZ. This disparity was
reflected in the WLRAZ with a mean of -1.65, but considerable variability (standard deviation
1.39) (Table 2). Head circumference was least impaired with a mean HCAZ of -0.66. Eighteen
percent of newborns in Arm 3 were stunted (LAZ <-2) and 42% were wasted (WLRAZ <-2).
For more than two-thirds of the newborns, the WLRAZ was <-1. Twelve percent were preterm deliveries; thirty-four percent had LBW, and 49% of Arm 3 were SGA. Head circumference was <-2 Z-scores in 11% of Arm 3.
Ninety-five percent CI for the positive effect sizes of the nutrition intervention
commencing � 3 months prior to conception (Arm 1) in comparison with control Arm 3 did
not include zero for LAZ, WAZ, and WLRAZ. In contrast, corresponding CI for effect sizes
for continuous variables for the nutrition intervention commencing in the first trimester of
pregnancy (Arm 2 vs. 3) included zero with the only exception of LAZ (Fig 2).
For binary variables, there was no reduction in relative risk for preterm delivery for either
the preconception (Arm 1) or 1st trimester intervention (Arm 2) compared to the control arm
(Arm 3). The intervention commencing in the preconception period (Arm 1) resulted in a
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Table 1. Overall baseline characteristics among women in South Asian study sites who had the primary outcome and gestational age available for newborns by
treatment arma.
Variable

Arm 2
(n = 337)

Arm 1
(n = 329)

Arm 3
(n = 295)

Maternal age, n (%)
79 (24.0)

80 (23.7)

61 (20.7)

20–24

<20

148 (45.0)

146 (43.3)

124 (42.0)

25 +

102 (31.0)

111 (32.9)

110 (37.3)

152 (46.2)

137 (40.7)

133 (45.1)

28 (8.5)

48 (14.2)

46 (15.6)

149 (45.3)

152 (45.1)

116 (39.3)

Maternal education, n (%)
No formal schooling
Primary
Secondary +
Body Mass Index (BMI), kg/m2
Mean ± SD
Median (P25—P75)

19.9 ± 3.1

19.7 ± 3.0

19.7 ± 3.1

19.4 (17.8, 21.7)

19.4 (17.6, 21.4)

19.3 (17.4, 21.5)

BMI < 20.0, n (%)

181 (55.0)

190 (56.4)

174 (59.0)

BMI < 18.5, n (%)

122 (37.1)

127 (37.7)

113 (38.3)

Height, cm, n
Mean ± SD
Median (P25—P75)

152.0 ± 5.9

151.2 ± 6.5

151.9 ± 6.2

151.9 (148.5, 156.0)

150.8 (147.0, 155.1)

151.5 (148.3, 156.0)
76 (25.8)

Parity, n (%)
0 (nulliparous)

110 (33.4)

85 (25.2)

1

111 (33.7)

118 (35.0)

95 (32.2)

�2

108 (32.8)

134 (39.8)

124 (42.0)

Tally of indicators of higher SESb, n (%)
None (0 present)

6 (1.8)

2 (0.6)

6 (2.0)

1–2 present

92 (28.0)

87 (25.8)

68 (23.1)

3–4 present

159 (48.3)

183 (54.3)

160 (54.2)

5–6 present

72 (21.9)

65 (19.3)

61 (20.7)

a

Primary outcome obtained from one or more newborn of the woman.
The socio-economic status (SES) tally provides the number of indicators available from the following list: electricity, improved water source, sanitation, man-made

b

flooring, improved cooking fuels, and household assets.
https://doi.org/10.1371/journal.pone.0218960.t001

reduction of 26% in the relative risk of SGA (p<0.0001) and a reduction in the incidence of
LBW of 19% ((RR 0.81 (0.66–1.00, p = 0.0461)) in comparison with control arm (Arm 3).
There were also substantial reductions (p<0.01) in the relative risks for stunting (LAZ <-2,
44%), underweight (WAZ <-2, 32%), and wasting (WLRAZ <-2, 24%) (Fig 3). For the intervention commencing in the first trimester (Arm 2) compared with the control arm (Arm 3),
several outcomes were marginally different (P<0.05) but none of these outcomes differed at α
= 0.01 level. Direct comparison of Arm 1 vs Arm 2 showed reduced risk for SGA, WAZ<-1
and WLRAZ<-1 for the preconception intervention. The only suggestion of the intervention
commencing at either time in relation to conception having a benefit on head size was a RR
for head circumference <3rd centile for Arm 1 vs. 3 of 0.73 (95% CI: 0.53–1.00).

Discussion
These newborn anthropometric outcomes for the combined data from the two S. Asian sites
included in the Women First trial demonstrate that substantial corrections of deficits in both
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Table 2. Women First Maternal Preconception Nutrition Trial in South Asia. Growth outcomes by treatment arm among all livebirths with gestational age at birtha
available and length measurements within 48 hours after birth.
Treatment Group
Variable

Arm 2
(n = 340)

Arm 1
(n = 333)

Arm 3
(n = 299)

Length (cm)
Mean ± SD
Median (P25, P75)

47.71 ± 2.21

47.60 ± 2.59

47.18 ± 2.60

47.90 (46.50, 49.00)

47.80 (46.30, 49.20)

47.40 (45.80, 48.80)

Length-for-Age Z-Score (LAZ)b
Mean ± SD

-0.62 ± 0.99

-0.69 ± 1.13

-0.90 ± 1.15

-0.55 (-1.24, -0.03)

-0.68 (-1.44, 0.07)

-0.88 (-1.74, -0.12)

LAZ <-1, n (%)

110 (33.0)

130 (38.2)

134 (44.8)

LAZ <-2, n (%)

33 (9.9)

45 (13.2)

53 (17.7)

Median (P25, P75)

Weight (gm)
Mean ± SD
Median (P25, P75)

2757 ± 451

2714 ± 459

2668 ± 431

2785 (2480, 3030)

2730 (2455, 3003)

2660 (2400, 2955)

Weight-for-Age Z-Score (WAZ)b
Mean ± SD

-0.98 ± 0.97

-1.11 ± 0.97

-1.20 ± 0.99

-0.98 (-1.63, -0.36)

-1.16 (-1.73, -0.43)

-1.25 (-1.97, -0.53)

WAZ <-1, n (%)

164 (49.2)

198 (58.2)

180 (60.2)

WAZ <-2, n (%)

52 (15.6)

55 (16.2)

68 (22.7)

Median (P25, P75)

Weight-Length Ratio-for-Age
Z-Score (WLRAZ)b,c
Mean ± SD

-1.38 ± 1.37

-1.58 ± 1.32

-1.65 ± 1.39

-1.35 (-2.30, -0.55)

-1.71 (-2.38, -0.65)

-1.70 (-2.67, -0.72)

WLRAZ <-1, n (%)

200 (61.0)

233 (69.1)

202 (68.5)

WLRAZ <-2, n (%)

105 (32.0)

126 (37.4)

125 (42.4)

Median (P25, P75)

Head circumference (HC, cm)d
Mean ± SD
Median (P25, P75)

32.94 ± 1.43

32.87 ± 1.55

32.78 ± 1.60

33.00 (32.00, 33.90)

33.00 (32.10, 33.80)

32.90 (32.00, 33.80)

HC-for-Age Z-Score (HCAZ)b,d
-0.55 ± 1.05

-0.62 ± 1.06

-0.66 ± 1.15

Median (P25, P75)

Mean ± SD

-0.60 (-1.27, 0.15)

-0.59 (-1.31, 0.01)

-0.70 (-1.44, -0.02)

HCAZ < -1, n (%)

116 (34.9)

119 (35.1)

110 (36.8)

HCAZ < -2, n (%)

27 (8.1)

29 (8.6)

32 (10.7)

121 (36.3)

148 (43.5)

147 (49.2)

Low birth weight (<2500 gm), n (%)

92 (27.6)

98 (28.8)

102 (34.1)

Preterm birth (<37 weeks GA), n (%)

41 (12.3)

29 (8.5)

37 (12.4)

Small for gestational age, n (%)e

a

Gestational age (GA) at birth is defined as the gestational age at the time of ultrasound measurement of fetal crown-rump length plus time until birth if the ultrasound

was done between 6 weeks + 0 days to 13 weeks + 6 days and the GA at birth is between 24 weeks + 0 days and 42 weeks + 6 days.
b
Length, weight, head circumference, and weight-length-ratio z-scores and percentiles based on measurements within 48 hours of age are calculated using the
International Standards for Newborn Size and International Standards for Newborn Size for Very Preterm Infants published by the INTERGROWTH-21st Project [37–
39] which provide Z-scores and percentiles by sex and GA at birth for infants born between 33 weeks + 0 days to 42 weeks + 6 days GA at birth and between 24 weeks
+ 0 days to 32 weeks + 6 days GA at birth respectively.
c

Arm 1 n = 328; Arm 2 n = 337; Arm 3 n = 295; total n = 960.

d

Arm 1 n = 332; Arm 2 n = 339; Arm 3 n = 299; total n = 970.
Small for Gestational Age (SGA) is a classification given to infants with a low birth weight, more specifically, a birth weight that is in 10th percentile or lower based on

e

standards by gestational age at birth and sex developed by INTERGROWTH-21st Project.
https://doi.org/10.1371/journal.pone.0218960.t002
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Fig 2. Women First Preconception Maternal Nutrition Trial: Effect sizes (95% confidence intervals) for continuous newborn
continuous anthropometric outcomes in South Asian region.
https://doi.org/10.1371/journal.pone.0218960.g002

weight and linear measures of fetal growth can be achieved with maternal nutrition supplements commenced in the first trimester or earlier. Despite lack of significant differences for
direct comparisons between Arms 1 and 2, the point estimates for the effect sizes were consistently more favorable for continuous and relative risks for binary anthropometric outcomes
for the preconception intervention. These advantages of improving the nutrient and energy
intake of women of childbearing age prior to conception were documented in S. Asian trial
populations unselected for past or current nutritional status. These rural populations were,
however, characterized by low income and sub-group dietary data in the first trimester documented low intakes of multiple micronutrients and, especially in India, borderline proteinenergy intake [40].
The goal of this trial was not to evaluate a specific nutrition product or combination of
products but rather to use these products to advance our understanding of the extent to which
deficits in fetal growth could be corrected by commencing nutrition interventions very early
in pregnancy or for a substantial time prior to conception in women of childbearing age in
these and similar populations. It is quite possible that greater effects could be achieved with
further modifications of the interventions, perhaps especially if guidelines for maternal gestational weight gain could be matched, and that these may be achievable with sustainable solutions including education and dietary improvements [41]. Meanwhile, the results of this trial
extend our knowledge of the extent to which fetal growth deficits in poor S. Asian populations
are attributable to undernutrition alone and can be corrected with nutrition interventions in
women of childbearing age.
This trial addressed persistent shared and prominent challenges in this region [1]. A trial of
iron-folate supplementation (IFS) early in this century documented a modest increase in birth
weight, reduction in risk of low birth weight, and increase in head circumference [42–44]. The
additional benefits of maternal multiple micronutrient supplements beyond those receiving
IFS alone, either as trial supplements or standard of care, have been reviewed in detail [45],
including data from India, Pakistan, Nepal, and Bangladesh. This analysis confirmed
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Fig 3. Women First Preconception Maternal Nutrition Trial: Relative risks (95% confidence intervals) for binary newborn
anthropometric outcomes in South Asian region. LAZ, length-for-age Z-score; SGA, small-for-gestational age; WAZ, weight-forage Z-score; WLRAZ, weight to length ratio-for-age Z-score.
https://doi.org/10.1371/journal.pone.0218960.g003

significantly but quite modestly lower relative risks for LBW, PTB, and SGA. A major contributor to this meta-analysis was the JiViTA-3 trial in Bangladesh, in which significant reductions
in LBW were attributable to a longer mean gestational age and lower incidence of PTB rather
than any effect on fetal growth rates [46]. This finding differed from the Women First trial in
which gestational ages at delivery were the same for the three trial arms. The prematurity incidence in the control arm for the S. Asian sites in the current study (12.4%) was similar to that
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recently estimated for S. Asia [47]. The results for the meta-analysis of Smith, et al., on birth
size were similar to those of an earlier meta-analysis of data from 12 sites [48] including four
in S. Asia, one each in Pakistan [49] and Bangladesh [50], and two in Nepal [42, 51]. There has
been only one lipid nutrition supplement trial in S. Asia that has been reported prior to
Women First [52]. In comparison with the IFS control arm, this trial in rural Bangladesh
resulted in statistically significant improvements in mean birth weight and length and in
binary outcomes associated with these measurements. However, with the exception of subgroup analyses and reduction in the rate of stunting, all improvements were very modest.
The effect sizes for continuous outcomes and relative risks for binary outcomes in the current study compared favorably with those of previous trials in S. Asian countries in terms of
improvements in fetal growth deficits whether the interventions were iron folate supplements,
multi-micronutrients, or lipid nutrition supplements. The extent of the contribution to favorable outcomes of the additional protein-energy supplements is unknown. These were provided
to two-thirds of Arm 1 participants prior to conception and to more than 90% of both Arm 1
and 2 participants during the 2nd and 3rd trimesters. Significant increases in birth weight
resulting from maternal balanced protein energy supplements during pregnancy have been
documented in S. Asia [53] and more widely [54]. However, this has not been a consistent
finding [55]. Perhaps relevant and in contrast to the results of the Women First trial [30], these
increases in birth weight in previous trials were specifically not accompanied by any increases
in birth length. Though we did not observe any statistical differences between Arms 1 and 2
for newborn LAZ, the preconception (Arm 1) anthropometric outcomes had the largest point
estimates for effect size compared to Arm 3 in this trial and compared favorably with corresponding outcomes of previous studies commenced during gestation. Both separately and
combined with the data for the first trimester arm, these results are strongly supportive of
commencing nutrition interventions as early as possible for women of childbearing age in
resource poor populations.
A limitation of this trial has been its inevitable restriction to only part of one maternal life
and to targeting only one environmental factor, namely maternal nutrition, when challenged
with a multifactorial etiology [56]. The strengths of this trial include an intervention relatively
comprehensive in nutrient content and quantity. The principal strength has been the early
start of the intervention, especially the preconception arm, and the inclusion of women of
childbearing age in these resource-poor communities irrespective of their long- or short-term
nutritional status as defined by anthropometric indices.

Conclusions
Newborn anthropometric data for the Women First trial in the S. Asian region (combined
data for the sites in India and Pakistan) provide further confirmation of the high incidence of
stunting, wasting, low birth weight, and SGA in this region. Commencing a relatively comprehensive nutrition supplement at least three months prior to conception for women unselected
for anthropometric indicators of nutritional status was associated with decreases of 44% in
stunting, 24% in wasting, and 26% SGA when compared to the control group. These results
provide quantitative information on the benefits to fetal growth achievable by improvement in
intake of energy, protein, and micronutrients commencing before the start of the second trimester of gestation without any other interventions directed to improvement of the poor environments in which the participants lived. Furthermore, the relatively large point estimates for
the effects of the nutrition supplement commenced � 3 months prior to conception support
enhanced efforts to improve the nutrition of all women of child-bearing age in resource-poor
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populations in these and similar environments in order to diminish impairment of fetal
growth.
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